Erratum: HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature

<b><i>Background:</i></b> Neuroendocrine carcinoma is an uncommon histology for breast cancer. <b><i>Case Report:</i></b> Our patient underwent right quadrantectomy for a neuroendocrine carcinoma in 1984 and had a bone relapse 30 years later. After thorough pathological and immunohistochemical analysis the diagnosis was confirmed and HER2 amplification was observed. Here we discuss the management, rationale and results of HER2-targeted therapy in advanced neuroendocrine breast carcinoma.